Novartis Gets Injunction Against Teva

A New Jersey jury has found in favor of Novartis AG and against Teva Pharmaceuticals USA Inc. on Wednesday in suit that Novartis filed claiming Teva infringed the patent for its genital herpes drug Famvir by seeking regulatory approval to market its own generic version.

This entry was posted on Sunday, November 22nd, 2009 at 10:49 am and is filed under Intellectual Property, Patents, Teva, US, infringement, pharmaceuticals, pharmaceuticals and Biotechnology. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply